SLN124
SLN124 is a GalNAc-conjugated siRNA therapeutic targeting TMPRSS6. It is designed to modulate iron homeostasis by inhibiting Tmprss6 expression, showing potential for research in iron overload disorders like β-thalassemia in both in vitro and in vivo models.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
